1. El Hamdaoui, Y., Zheng, F., Fritz, N. et al. Analysis of hyperforin (St. John’s wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs. Mol Psychiatry 27, 5070–5085 (2022).
  2. Borsini, A., Zunszain, P. A., Thuret, S., and Pariante, C. M. (2015). The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 38, 145–157. doi: 10.1016/j.tins.2014.12.006
  3. Friedli, M.J.; Inestrosa, N.C. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease. Molecules 2021, 26, 6531.
  4. Alfredo Vannacci; Effects of 12-Week Bacopa monnieri Consumption on Attention, Cognitive Processing, Working Memory, and Functions of Both Cholinergic and Monoaminergic Systems in Healthy Elderly Volunteers;
  5. Amenta F., Tayebati S.K., Vitali D., Di Tullio M.A. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: An approach for enhancing cholinergic neurotransmission. Mech. Ageing Dev. 2006;127:173–179. doi: 10.1016/j.mad.2005.09.017.
  6. Lee S.H., Choi B.Y., Kim J.H., Kho A., Sohn M., Song H.K., Choi H.C., Suh S.W. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment. Brain Res. 2017;1654:66–76. doi: 10.1016/j.brainres.2016.10.011.
  7. Parnetti L., Abate G., Bartorelli L., Cucinotta D., Cuzzupoli M., Maggioni M., Villardita C., Senin U. Multicentre Study of l-??-Glyceryl-Phosphorylcholine vs ST200 among Patients with Probable Senile Dementia of Alzheimer??s Type. Drugs Aging. 1993;3:159–164. doi: 10.2165/00002512-199303020-00006.
  8. Moreno M.D.J.M. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. Clin. Ther. 2003;25:178–193. doi: 10.1016/S0149-2918(03)90023-3.
  9. Parnetti L., Mignini F., Tomassoni D., Traini E., Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for re-evaluation? J. Neurol. Sci. 2007;257:264–269. doi: 10.1016/j.jns.2007.01.043.
  10. Robinson S., Sandstrom S.M., Denenberg V.H., Palmiter R.D. Distinguishing Whether Dopamine Regulates Liking, Wanting, and/or Learning About Rewards. Behav. Neurosci. 2005;119:5–15. doi: 10.1037/0735-7044.119.1.

Contact phone number: +1 (720) 807-2142

Legal Notice
Privacy Policy

Copyright © 2023
Unauthorized duplication or publication of any materials from this site is expressly prohibited.